ERLONAT 100

ERLONAT 100

Product Details:

  • Drug Type Specific Drug
  • Ingredients ERLOTINIB 150
  • Physical Form Tablets
  • Function Cancer Treatment
  • Recommended For LUNG CANCER,PANCREATIC CANCER
  • Dosage The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions Pulmonary† Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* Hepatic† Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider
  • Suitable For Aged Person, Adults, Teenagers
  • Supply Ability : 20 Bottle Per Week
122.96-136.63 USD ($)/Bottle
X

Price And Quantity

  • 122.96-136.63 USD ($)/Bottle
  • 2 Bottle

Product Specifications

  • ERLOTINIB 150
  • ROOM TEMP. 10 -30 C
  • Aged Person, Adults, Teenagers
  • Cancer Treatment
  • Specific Drug
  • The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions Pulmonary† Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* Hepatic† Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider
  • LUNG CANCER,PANCREATIC CANCER
  • Tablets

Trade Information

  • Cash in Advance (CID)
  • 20 Bottle Per Week
  • 2 Week
  • 1*30S
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

USES OF ERLONAT TABLET

Non-small cell lung cancer
Pancreatic cancer

BENEFITS OF ERLONAT TABLET

In Non-small cell lung cancer

Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlonat 150 Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

SIDE EFFECTS OF ERLONAT TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're worried about them

Common side effects of Erlonat

  • Abdominal pain
  • Bone painBreathlessness
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Infection
  • Muscle pain
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weight loss

HOW TO USE ERLONAT TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlonat 150 Tablet is to be taken empty stomach.

HOW ERLONAT TABLET WORKS

Erlonat 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.


SHRESTHA GLOBAL PHARMA

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Listen to the Code(Audio Link)


Back to top
SHRESTHA GLOBAL PHARMA All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.